Cargando…
Anti‐FIRΔexon2, a splicing variant form of PUF60, autoantibody is detected in the sera of esophageal squamous cell carcinoma
Anti‐PUF60 autoantibodies are reportedly detected in the sera of patients with dermatomyositis and Sjögren's syndrome; however, little is known regarding its existence in the sera of cancer patients. FIR, a splicing variant of the PUF60 gene, is a transcriptional repressor of c‐myc. In colorect...
Autores principales: | Kobayashi, Sohei, Hiwasa, Takaki, Ishige, Takayuki, Rahmutulla, Bahityar, Kano, Masayuki, Hoshino, Tyuji, Minamoto, Toshinari, Shimada, Hideaki, Nomura, Fumio, Matsubara, Hisahiro, Matsushita, Kazuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549911/ https://www.ncbi.nlm.nih.gov/pubmed/30980774 http://dx.doi.org/10.1111/cas.14024 |
Ejemplares similares
-
Anti-FIRs (PUF60) auto-antibodies are detected in the sera of early-stage colon cancer patients
por: Kobayashi, Sohei, et al.
Publicado: (2016) -
Anti‐FIRΔexon2 autoantibody as a novel indicator for better overall survival in gastric cancer
por: Kobayashi, Sohei, et al.
Publicado: (2021) -
Post-transcriptional regulation of BRG1 by FIRΔexon2 in gastric cancer
por: Ailiken, Guzhanuer, et al.
Publicado: (2020) -
Disturbed alternative splicing of FIR (PUF60) directed cyclin E overexpression in esophageal cancers
por: Ogura, Yukiko, et al.
Publicado: (2018) -
Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library
por: Kobayashi, Sohei, et al.
Publicado: (2018)